36C10G18Q9144-002.pdf
PDF 63 KB Posted
- Attached to
- NX EQ Ophthalmic Perimeters (VA-18-00063381)
- Solicitation number
- 36C10G18Q9144
About this file
36C10G18Q9144 ATTACHMENT B - OPHTHALMIC PERIMETERS - PRODUCT DESCRIPTION.pdf
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C10G18Q9144-0001000.docx | DOCX document | |
| 36C10G18Q9144-004.docx | DOCX document | |
| 36C10G18Q9144-005.docx | DOCX document | |
| 36C10G18Q9144-001.xlsx | XLSX spreadsheet | |
| 36C10G18Q9144-006.xlsx | XLSX spreadsheet | |
| 36C10G18Q9144-000.docx | DOCX document | |
| 36C10G18Q9144-003.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PRODUCT DESCRIPTION
For
NON-EXPENDABLE EQUIPMENT:
OPHTHALMIC PERIMETERS
Prepared By:
Strategic Acquisition Center
Department of Veterans Affairs 10300 Spotsylvania Avenue, Suite 400 Fredericksburg, VA 22408
1. SCOPE OF WORK:
The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Ophthalmic Perimeters product line as a candidate for a VA-wide (otherwise referred to as “national”) single Requirements contract award.
Ophthalmic Perimeters are designed to evaluate the sensitivity of discrete areas of the retina (visual field) through responses to light stimuli. These devices can determine the central and peripheral visual field and the areas of lost or depressed vision (scotomas).
Perimeters are used to detect and evaluate abnormalities that cause constriction of the peripheral vision (e.g. retinitis pigmentosa) or that affect peripheral or central vision, or both. They also detect and evaluate abnormalities in the eye, optic nerve, or brain that cause constriction of the peripheral vision.
The Contractor must demonstrate the ability to meet all requirements for the solicitation.
The objective is to provide Ophthalmic Perimeters to be used by clinicians throughout the VA medical centers and facilities. The period of performance is for one (1) 12 month base period with two (2) twelve (12) month option periods.
2. REQUIREMENT
This requirement will be IAW FAR clause 52.211-6, “Brand Name or Equal” which requires the Quoter indicate that each product being offered as an “equal” product to the Zeiss® Ophthalmic Perimeters. For each equal product, the offeror must include a description reflecting the salient characteristics (SC) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The Quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the Quoter must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the contracting officer, and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.
Contract
Line Items
Manufacture Part Number Description
0001 Carl Zeiss 266002-1162-270 HFA3 Model 860 with SITA Faster, Liquid Trial Lens, GPA, Head Tracking, Gaze Tracking, Auto Pupil, Foveal Threshold, Red Blue Stimulus Color, Kinetic, Custom Kinetic Pattern, SWAP, Vertex Monitor, RelEYE – INCLUDES: Printer & Table
The Department of Veterans Affairs (VA) is seeking vendors who can provide Zeiss® brand of Ophthalmic Perimeters as listed above or equal commodities which meet all the following salient characteristics:
SC # SALIENT CHARACTERISTIC METHOD OF
EVALUATION
SC 1 Review eye position, at any stimulus point Literature Review
SC 2
Kinetic graphical user interface; with a maximum binocular testing range of 180° degrees. (Temporal range of 90 degrees each eye)
Literature Review
SC 3
Fixation Controls, Heijl-Krakau blind spot monitor, Video eye monitor, Gaze tracking, Head tracking, Vertex monitoring
Literature Review
SC 4 Capable of preforming Kinetic and Static testing Literature Review
SC 5 Progression Analysis on multiple testing strategies (standard and fast-testing)
Literature Review
SC 6
Uses event and trend analysis along with a center-weighted staging index to identify and quantify visual field progression.
Literature Review
SC 7 Testing results transferable to an image management system to track changes over a period of time
Literature Review
SC 8 Availability of multiple stimuli: white on white; red/blue on white; blue on yellow
Literature Review
SC 9 Must have DICOM connectivity software features Literature Review
SC 10 Federal Drug Administration (FDA), Class 2 Medical Device
Literature Review
File details come from the government source that posted it.